Skip to content
drillr.ai
Sign up

HBIO

Harvard Bioscience, Inc.

NASDAQ · Healthcare · Medical - Instruments & Supplies · US

$8.02
+0.25%
Ask drillr

  • Aug 11, 2026, 17:47 UTC

    Harvard Bioscience, Inc. held its Q2 2026 earnings call on August 11, 2026, discussing financial results for the quarter.

    Source:

  • Jun 2, 2026, 00:00 UTC

    Harvard Bioscience Inc elected John Duke and Katherine A. Eade as Class II Directors effective June 2, 2026.